NA-not applicable; LSPC-Long standing pancolitis (>20 years disease duration); ROUC-Recent onset UC (<5 years disease duration); PSC-primary sclerosing cholangitis associated colitis; ACT-rectal biopsies from patients with actively inflamed distal colitis; INACT-biopsies proximal un-inflamed segment from patients in ACT group; DT-biopsies from the dysplastic segment;DR-biopsies from rectum in patients with dysplasia elsewhere in the colon.
Section 3 Cell Culture and IF extraction

Cell cultures
The breast adenocarcinoma cell line, MCF-7 was obtained from American Type Culture and western immunolotting [29] . Briefly, colonic biopsies were processed sequentially in low and high detergent buffers (LDB and HDB) by a process of homogenization and centrifugation to yield the insoluble cytoskeleton fraction. This fraction was dissolved in 4M guanidine hydrochloride (GuHCl) (Sigma-Aldrich, Dorset UK) dissolved in triethyl ammonium bicarbonate buffer (TEAB) at a pH of 8.5 (Sigma-Aldrich, Dorset UK). Extraction of insoluble
IFs from MCF-7 was undertaken as previously described [29] .
Assay of protein concentration in GuHCl solubilised samples
The insoluble IF pellet obtained from the colonic biopsies were solubilized in 20μL of 4M iTRAQ labeled samples were incubated at room temperature for 2 hours followed by pooling in a 1:1 ratio. The pooled mixture was dried in a vacuum centrifuge (Eppendorf Concentrator 5301) and was reconstituted in 90 μl of 20% acetonitrile (ACN), 0.1% formic acid and the pH of the solution was adjusted to 2. This reconstituted peptide mixture underwent sonication followed by centrifugation to remove insoluble material.
Strong Cation Exchange Fractionation of Peptides
Briefly, SCX was carried out using a PolySULFOETHYL™ A Column (PolyLC, Columbia, MD) 5µm particle size of 200mm length×4.6mm id, 200Å pore size, on a BioLC HPLC unit (Dionex, Surrey, UK). The 60-min gradient was generated between Buffer A (20% v/v acetonitrile, 0.1% v/v formic acid), and Buffer B (20% acetonitrile and 500mM KCl, 0.1% v/v formic acid), and consisted of 100% A for 5min, 5-30% B for 40 min, 30-100% B for 5min, 100% B for 5 min and finally 100% A for 5min. The chromatogram was monitored through a UV Detector (Dionex/LC Packings, Amsterdam, the Netherlands), at a wavelength of 214nm. Fractions were collected every minute and were later pooled together according to variations in peak intensity. SCX fractions were dried in a vacuum concentrator, and stored at −20°C prior to mass spectrometric analysis.
Tandem mass spectrometry (MS/MS) Analysis
An Ultimate 3000 capillary nano-LC ( 
iTRAQ data analysis
The mass-spectrometric data was collected and analysed as previously described [3, (Majumdar et al., 2012) . Briefly, MS/MS data generated from the QSTAR ® XL was first converted to generic MGF peaklists using the mascot.dll embedded script (version 1.6 release no. 25) in Analyst QS v. scan, were also median corrected using the same factors, with the rationale that if the total concentration of a sample A was half that of another sample B, the intensities of sample A's reporter have to be doubled to allow for a fair comparison. t-tests applied to determine alterations in protein level between samples use these corrected intensities since these were was carried out for every protein and because of the multiple times each test was performed, the threshold (α=5%) used for significance was corrected for data mining. Here, we used the standard Bonferroni correction (α/P, where P is the number of proteins) to minimise false positive results. This workflow was developed in house (3)
B Label free MS analysis
Complex tryptic peptide mixtures were separated using nanoscale chromatography performed using a nanoACQUITY UPLC (Waters Corporation, USA). FWHM. In all experiments the mass spectrometer was programmed to step between low energy (4 eV) and elevated (14-40 eV) collision energies on the Triwave collision cell, using a scan time of 0.9 s per function over 50-2000 m/z. All samples were analyzed in duplicate.
Analysis of label free HDMS E data
Data processing and database searching was performed using and a UniProt human database using algorithm of Progenesis QI software as described by (Li et al., 2009 , Proteomics 6:1696 
Section 5 SDS-PAGE and Western Transfer
Quantitative analysis of immunoblot was performed using densitometry. The Chemigenius Bio-Imaging System and Gene Tools software (Syngene, Cambridge, UK), were used. .
Individual bands of interest were selected manually and their densities were calculated. The software was used to automatically correct any background intensity. Densitometry results to calculate the proportion of phosphorylated K8 were normalised to the MCF-7 internal standard and calculated as follows: Phosphorylated K8 band intensity/MCF-7 band intensity was calculated (x). Total K8 band intensity/MCF-7 band intensity was calculated (y). x/y would equate to the phosphorylated K8 ratio. Finally the results were transferred to Microsoft Excel (Microsoft Corporation, Redmond, USA).
Coomassie staining of the gels was performed separately using Instant Blue (Expedeon,
Harston, UK) in order to visualise the protein bands.
Section 6 Proteomic Data
A graphical summary of the workflow, relating the pooling and unpooled analysis and tiers of orthogonal validation. 
